Guardian Pharmacy Services, Inc. (GRDN)
49.52
+0.14
(+0.28%)
USD |
NYSE |
Nov 13, 16:00
49.49
-0.03
(-0.06%)
Pre-Market: 19:59
Guardian Pharmacy Services Enterprise Value : 3.065B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 3.065B |
| November 12, 2026 | 3.056B |
| November 11, 2026 | 3.094B |
| November 10, 2026 | 3.086B |
| November 09, 2026 | 2.907B |
| November 06, 2026 | 2.614B |
| November 05, 2026 | 2.454B |
| November 04, 2026 | 2.595B |
| November 03, 2026 | 2.517B |
| November 02, 2026 | 2.462B |
| October 30, 2026 | 2.506B |
| October 29, 2026 | 2.491B |
| October 28, 2026 | 2.483B |
| October 27, 2026 | 2.434B |
| October 26, 2026 | 2.411B |
| October 23, 2026 | 2.427B |
| October 22, 2026 | 2.436B |
| October 21, 2026 | 2.398B |
| October 20, 2026 | 2.581B |
| October 19, 2026 | 2.471B |
| October 16, 2026 | 2.429B |
| October 15, 2026 | 2.442B |
| October 14, 2026 | 2.499B |
| October 13, 2026 | 2.450B |
| October 12, 2026 | 2.492B |
| Date | Value |
|---|---|
| October 09, 2026 | 2.543B |
| October 08, 2026 | 2.563B |
| October 07, 2026 | 2.505B |
| October 06, 2026 | 2.538B |
| October 05, 2026 | 2.595B |
| October 02, 2026 | 2.613B |
| October 01, 2026 | 2.515B |
| September 30, 2026 | 2.512B |
| September 29, 2026 | 2.534B |
| September 28, 2026 | 2.538B |
| September 25, 2026 | 2.567B |
| September 24, 2026 | 2.604B |
| September 23, 2026 | 2.697B |
| September 22, 2026 | 2.787B |
| September 21, 2026 | 2.754B |
| September 18, 2026 | 2.807B |
| September 17, 2026 | 2.811B |
| September 16, 2026 | 2.904B |
| September 15, 2026 | 2.997B |
| September 14, 2026 | 2.902B |
| September 11, 2026 | 2.721B |
| September 10, 2026 | 2.733B |
| September 09, 2026 | 2.705B |
| September 08, 2026 | 2.646B |
| September 04, 2026 | 2.540B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Medical Care Technologies, Inc. | 0.3186M |
| Cosmos Health, Inc. | 27.05M |
| Organogenesis Holdings, Inc. | 291.18M |
| cbdMD, Inc. | 4.254M |
| Agape ATP Corp. | -23.24M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 19.12M |
| Revenue (Quarterly) | 371.07M |
| Total Expenses (Quarterly) | 352.39M |
| EPS Diluted (Quarterly) | 0.2923 |
| Gross Profit Margin (Quarterly) | 22.97% |
| Profit Margin (Quarterly) | 5.15% |
| Earnings Yield | 2.37% |
| Operating Earnings Yield | 2.92% |
| Normalized Earnings Yield | 2.328 |